# Northwest Biotherapeutics Inc: Form 10-K/A for the period ended Dec 31, 2021

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 10-K/A
- Filed: 2022-06-30
- Accepted by EDGAR: Jun 30, 2022, 17:08 ET
- Period: 2021-12-31
- Accession: 0001104659-22-076361
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465922076361/tm2220145d1_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465922076361/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465922076361/tm2220145d1_10ka.htm

Filed Jun 30, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-076361. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.